Viewing nowCombinationSeltoforizik 10/160 Milligrams
Amlodipine Besylate 13.87mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201902727 · Approved 2019.04.29 · Insurance code 693902980
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively control blood pressure in patients with essential hypertension whose blood pressure is not well controlled with monotherapy of amlodipine or valsartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, a direct switch to this medicine may be considered when blood pressure is not adequately controlled with monotherapy with an individual component, as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams monotherapy, or with 5/160 milligrams. Patients currently taking valsartan and amlodipine in combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more), but this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, and should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this medication's active ingredients or similar class of drugs, pregnant or breastfeeding women, and patients with severe kidney or liver disease should not take this medication. Patients with fluid or sodium deficiency, hyperkalemia, renal artery stenosis, recent kidney transplant, history of angioedema, heart failure, or post-myocardial infarction, aortic stenosis should use this medication with caution. While taking this medication, side effects such as hypotension, dizziness, headache, swelling, skin rash, dyspepsia may occur; if any abnormal symptoms arise, consult a physician or pharmacist. Caution is advised as intermittent dizziness or fatigue may occur while driving or operating machinery. This medication may interact with other antihypertensives, potassium supplements, certain diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), so inform your healthcare provider about any medications you are taking. Pregnant women or those planning to become pregnant should not take this medication, and it is also not recommended for breastfeeding women. Safety and efficacy have not been adequately established for patients under 18 years old, so its use in this population is not recommended. Overdose may result in severe hypotension or shock; hence, it is crucial to adhere to the prescribed dosage and seek immediate medical attention if abnormal symptoms occur.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, postural dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, itching, joint swelling, lumbar pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, limb edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, reduced hemoglobin, reduced hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory deficit, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuropathic irritability, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to keep air and moisture out, and it is best kept at room temperature between 1 to 30 degrees Celsius. This way, the effectiveness of the medication can be well maintained.
Bright yellow rectangular film-coated tablets
30 tablets/box [(10 tablets/Alu-Alu x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 13.87mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.